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Background: Clinical scores for sepsis have been primarily developed for, and applied in High-Income Coun-
tries. This systematic review and meta-analysis examined the performance of the quick Sequential Organ
Failure Assessment (qSOFA), Systemic Inflammatory Response Syndrome (SIRS), Modified Early Warning
Score (MEWS), and Universal Vital Assessment (UVA) scores for diagnosis and prediction of mortality in
patients with suspected infection in Low-and-Middle-Income Countries.
Methods: PubMed, Science Direct, Web of Science, and the Cochrane Central Register of Controlled Trials
databases were searched until May 18, 2021. Studies reporting the performance of at least one of the above-
mentioned scores for predicting mortality in patients of 15 years of age and older with suspected infection
or sepsis were eligible. The Quality Assessment of Diagnostic Accuracy Studies tool was used for risk-of-bias
assessment. PRISMA guidelines were followed (PROSPERO registration: CRD42020153906). The bivariate
random-effects regression model was used to pool the individual sensitivities, specificities and areas-under-
the-curve (AUC).
Findings: Twenty-four articles (of 5669 identified) with 27,237 patients were eligible for inclusion. qSOFA
pooled sensitivity was 0¢70 (95% confidence interval [CI] 0¢600¢78), specificity 0¢73 (95% CI 0¢670¢79), and
AUC 0¢77 (95% CI 0¢720¢82). SIRS pooled sensitivity, specificity and AUC were 0¢88 (95% CI 0¢79 -0¢93), 0¢34
(95% CI 0¢250¢44), and 0¢69 (95% CI 0¢500¢83), respectively. MEWS pooled sensitivity, specificity and AUC
were 0¢70 (95% CI 0¢57 -0¢81), 0¢61 (95% CI 0¢420¢77), and 0¢72 (95% CI 0¢640¢77), respectively. UVA
pooled sensitivity, specificity and AUC were 0¢49 (95% CI 0¢33 -0¢65), 0¢91(95% CI 0¢840¢96), and 0¢76 (95%
CI 0¢440¢93), respectively. Significant heterogeneity was observed in the pooled analysis.
Interpretation: Individual score performances ranged from poor to acceptable. Future studies should combine
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Sepsis is defined as life-threatening organ dysfunction caused by a
dysregulated host response to infection; it is responsible for twenty
percent of all-cause global mortality, the majority of which occurs in
low-and-middle-income countries (LMICs) [1,2].
Sepsis is a syndrome that can manifest in affected patients as a
broad constellation of symptoms and signs caused by the interplay of
pathogens and host factors. To address the challenge of sepsis diag-
nosis, multiple sepsis diagnostic and mortality prediction models or
scores have been developed.
The availability of sophisticated laboratory investigation tools and
early warning scores are important instruments to improve diagnosis
and management of sepsis in high-income countries (HICs), but
applying those to LMIC settings is complex. The first early warning
score published in 1997 was designed to enable detection of changes
in illness severity using aberrations in vital signs. In 2001, the Modi-
fied Early Warning Score (MEWS) was published. It was created by
assigning weighted scores to five physiological parameters (systolic
blood pressure, pulse rate, respiratory rate, temperature and level of
consciousness) based on severity of the abnormality [3]. Though not
specific for sepsis, MEWS is intended to support medical staff in
anticipating patients’ clinical deterioration.Sepsis definitions have been modified significantly between 1991
and 2016 [4]. The current definition describes sepsis as organ dys-
function caused by dysregulated host response to infection. For clini-
cal operationalisation, organ dysfunction is represented by an
increase in the Sequential (sepsis-related) Organ Failure Assessment
(SOFA) score of two points or more [5]. The preceding sepsis screen-
ing tool utilised the systemic inflammatory response syndrome
(SIRS) criteria but was suggested to be abandoned by the Third Inter-
national Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
task force due to concerns about its lack of specificity in identifying
patients with severe disease resulting in potential over-treatment of
patients with milder disease [5]. SOFA, however, requires laboratory
values which may not be readily available outside of a highly
resourced intensive care unit (ICU). Accordingly, the quick SOFA
(qSOFA) score was proposed as a screening tool to identify patients at
high risk of poor outcome [5].
MEWS, SIRS and qSOFA were mainly developed in HICs. LMICs
share a high burden of many infectious diseases, for which sepsis is
the common final pathway. Studies validating these scores in LMICs
are limited, with performances differing from one study to another
[69]. Recently, the Universal Vital Assessment (UVA) score was
developed, using multiple cohorts of patients from sub-Saharan Afri-
can countries with suspected infection, demonstrating good perfor-
mance in predicting in-hospital mortality [10]. The UVA score
included points for systolic blood pressure, Glasgow Coma Scale
score, temperature, oxygen saturation, respiratory and heart rates,
and humon immunodeficiency virus (HIV) serostatus [10]. Its perfor-
mance has been assessed by now in several studies in Africa [7,11]. In
LMICs, there are limited healthcare resources and ICU facilities. As a
consequence, severe and critically-ill patients cannot always be
admitted to an ICU. Therefore, an applicable triage score that is easily
applied by frontline clinicians is paramount in order to prioritise
care. Previous systematic reviews assessed the performance of the
qSOFA, SIRS, and MEWS scores, but did not focus on LMICs [12]. Com-
pared with SIRS, qSOFA showed better specificity for predicting mor-
tality but lower sensitivity for identifying patients with sepsis in
patients with suspected infection [6,13]. It is well-known that setting
and study population might influence the accuracy of screening and
diagnostic testing [14]. This systematic review and meta-analysis
assessed the performance of four available scores (qSOFA, SIRS,
MEWS, UVA) in the diagnosis of sepsis and in-patient mortality pre-
diction in adult non-pregnant and non-surgical patients with sus-
pected infections in LMICs.2. Methods
2.1. Search strategy and selection criteria
This systematic review and meta-analysis followed the recom-
mendations of the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) statement extension for Diagnostic Test
Accuracy (DTA) [15]. An electronic search of the published literature
was conducted on November 04, 2019 and updated on May 18, 2021
in PubMed, Science Direct, Web of Science, and the Cochrane Central
Register of Controlled Trials. We used the following search terms:
‘qsofa’, ’sofa’, ‘sirs,’ ‘UVA’, ’MEWS’, ‘sequential organ failure assess-
ment’, ‘systemic inflammatory response syndrome’, ‘Universal Vital
Assessment’, ’Early Warning Score’, ‘sepsis’, ‘infections’. In addition,
we used a filter suggested by the Cochrane Collaboration based on
the World Bank list of low-income, lower-middle-income or upper-
Figure 1. Diagram of the study selection process.
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and relevant references cited in those articles were reviewed. The full
search strategy used is reported in Supplementary File S1.
Studies which recruited patients 15 years of age and older with
suspected infection or sepsis were eligible for inclusion using the fol-
lowing criteria: (1) full-length reports published in peer-reviewed
journals; (2) observational studies or clinical trials of adult (>15
years old) patients; (3) studies that describe data about sepsis assess-
ment using at least one of the four scores; and (4) studies that report
the relationship between the sepsis screening criteria and at least
one of the following outcomes: sensitivity or specificity for diagnosis
of sepsis (organ dysfunction, SOFA 2), deaths that occurred in hospi-
tal, or any post-hospital discharge outcomes. According to the pub-
lished definitions, qSOFA was considered positive when at least two
variables met fulfilment criteria’; SIRS when at least two criteria
were met; MEWS when at least five score criteria were met; and UVA
when at least five score criteria were met. The details of each score
are provided in Supplementary File S2. We excluded studies which
were not performed in LMICs, studies which did not report sensitiv-
ity, specificity, or data to calculate the score performance characteris-
tics, and studies limited to specific patient populations (such as
COVID-19 or pneumonia patients). Two investigators (WNN & LBD)
independently screened studies for eligibility; disagreement was
resolved by consensus. If WNN and LBD did not agree after discus-
sion, a third investigator (BRA) was consulted. The study protocol
was registered with the International Prospective Register of System-
atic Reviews (PROSPERO; CRD42020153906; available from: https://
www.crd.york.ac.uk/prospero/display_record.php?
ID=CRD42020153906) and amended once.
2.2. Data extraction and quality assessment
The following data were extracted from the original studies:
first author; year of publication; country of origin; study design;
sample size; mortality rate; patient selection criteria; score evalu-
ated, objectives and outcomes. In case of missing information, we
contacted the respective corresponding authors. BRA and JRE
independently extracted potentially relevant studies and
reviewed each study according to the pre-defined eligibility crite-
ria. The primary outcome was overall mortality (in-hospital or
28/30 days mortality). The secondary outcome was diagnosis of
sepsis (acute organ dysfunction).
The Quality Assessment of Diagnostic Accuracy Studies (QUA-
DAS)-2 tool was used to assess the risk of bias in diagnostic test accu-
racy [17], as recommended by the Cochrane Collaboration.
Consensus on the risk of bias was sought by two reviewers (BRA and
WNN). A detailed quality assessment is provided in Supplementary
File S3; articles rejected are listed in Supplementary File 4.
2.3. Data analysis
Statistical analysis was conducted using RevMan5.4 (Nordic
Cochrane Center, Copenhagen, Denmark) [18] and RStudio 4.0.2 (250
Northern Ave, Boston, USA) [19]. We generated true positives, false
negatives, false positives, and true negatives based on sensitivity,
specificity, and 95% confidence intervals (CIs) of each study using
RevMan5.4. We used the packages ‘meta’ [20] and ‘mada’ (version
0.5.10) [21] in CRAN-R to produce the meta-analysis forest and funnel
plots. Between studies, statistical heterogeneity was assessed using
the I2 statistic and Cochran’s Q test; I2 values of more than 50% indi-
cated a significant level of heterogeneity. Funnel plots were used to
assess publication bias (Supplementary File S5). Pooled sensitivity
and specificity were calculated using a bivariate random-effects
regression model. The summary receiver operator curves were con-
structed, and the area under the curve (AUC) was used to appreciate
the discriminatory performance of each score.2.4. Ethics information
No ethical clearance was required for this systematic review and
meta-analysis.
2.5. Role of the funding source
The supporting funder of the study had no role in study design,
data collection, data analysis, data interpretation, or writing of the
report. The corresponding author, Martin P. Grobusch accessed the
dataset, and the decision to submit for publication was jointly taken
by all authors.
3. Results
In total, 8526 published articles were initially identified (3741
articles from PUBMED, 136 articles from Science Direct, 2093 articles
from the Cochrane Library, and 2556 on Web of Science). After
removing duplicate articles, 5669 potentially eligible articles were
screened. Of these articles, 5495 were excluded on the basis of title
and abstract. A total of 174 articles underwent full-text review. One
hundred fifty-five articles were excluded for the reasons presented in
Figure 1. Finally, a total of 24 articles met our inclusion criteria for
the systematic review and meta-analysis.
All studies were published between 2013 and 2021. Characteris-
tics of the studies included are presented in Table 1. The number of
patients per study ranged from 64 to 6218, and the overall mortality
rate in each study ranged from 3¢8 % to 61¢0%. Across studies, the two
most-frequently reported conditions were respiratory tract infections
and malaria.
Twenty-three studies reported qSOFA (26,460 participants) score
performance; twelve (15,401 participants) reported SIRS perfor-
mance, nine reported MEWS (13,063 participants), and four reported
UVA (6841 participants). Six studies compared the accuracy of qSOFA
and SIRS, five studies compared qSOFA and MEWS, and three studies
compared qSOFA and UVA criteria. One study compared all four
scores. Two studies reported the performance of qSOFA in the diag-
nosis of sepsis. All studies included were observational. More than
half were prospective. The studies were well designed, the quality
assessment demonstrated a low risk of bias. The detailed QUADAS-2
assessment is presented in Supplementary File S3.
Table 1
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38 (2853) 11/187(6) To evaluated the ability of the qSOFA
score to predict mortality in patients
presenting to the emergency depart-
ment, and compared the performance
of qSOFA with the SIRS criteria, MEWS,
and UVA scores.






30 (2340) 32/519(6) To evaluate the prognostic accuracy of
qSOFA for 28-day all-cause mortality
in febrile adult patients treated at
emergency departments and to com-







Malawi Prospective General wards 40 (1898) 44/413(10) To evaluate the predictive value of a
qSOFA score of 2 for mortality among
hospitalised adults and among those
with suspected infection.
Not reported qSOFA
Luo et al (2019)[33] China Prospective General wards 55(40-67) 32/409(7.8) To evaluate the ability to diagnostic sep-





Yu et al (2019)[27] China Retrospective Emergency
department
62 (4774) 178/1318(13.5) To determine the ability of qSOFA to pre-
dict in hospital mortality in a multi-
center cohort of patients who






Tian et al (2019)[34] China Retrospective General wards 79(6185) 353/1716(21) 1-To evaluate the accuracy of qSOFA for
the diagnosis of sepsis-3 2-To evaluate
the performance of qSOFA as one pre-






Wei et al (2019)[35] China Retrospective Emergency
department
44.5(18.3) 213/4857(4.4) To evaluate the performance of MEWS in
predicting the outcomes of adult










59.6(18.3) 52/383(13.6) To validate the performance of MEWS in
a Chinese emergency department and














Retrospective General wards 38(36-55) 643/6218(10) To assess the association of qSOFA with
excess hospital death among patients
with suspected infection in LMICs and
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Malawi Prospective General wards 35(26-47) 106/458(23) To determine the predictive value of
qSOFA in Malawian patients with sus-
pected infection
Not reported qSOFA






Retrospective General wards 36(27-49) 966/5573(18) To determine predictors of mortality
UVA score and compare the perfor-
mance of the UVA score in predicting
mortality with that of MEWS and
qSOFA.
Not reported UVA, qSOFA,
MEWS
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Muhammad et al [a]
(2018) [39]
Pakistan Prospective Intense care unit 60.2(17.9) 208/339(61) To determine a comparison between the
qSOFA score and SOFA when applied to
septic shock patients in the Emergency
Department for prediction of in-hospi-
tal mortality in the setting of a tertiary






Muhammad et al [b]
(2018) [39]
Pakistan Prospective Intense care unit 59.6(17.2) 242/421(57.5) To determine a comparison between the
qSOFA score and SOFA when applied to
severe sepsis patients in the Emer-
gency Department for prediction of in-
hospital mortality in the setting of a










Not reported 8/64(12.5) To determine the ability of the
mMEDS score, the MEWS score and the
CCI to predict prognosis in patients
presenting to the ED of our hospital
who are diagnosed with sepsis
Not reported MEWS




Not reported 66/166(39¢8) To determine the ability of the
mMEDS score, the MEWS score and the
CCI to predict prognosis in patients
presenting to the ED of our hospital




Thailand Retrospective Intense care unit 62(44-75) 1045/2350(44¢5) To compare the SOFA score and qSOFA to
SIRS criteria ability in predictive of in





Huson et al (2016)
[38]
Gabon Retrospective All wards 34 (24-46) 15/329(4¢56) To determine the predictive value of
qSOFA in patients with suspected
infection in a hospital with limited
supportive care facilities, in Gabon.
Malaria 122 (37) qSOFA




51 (38-60) 454/1213(37¢4) To investigate the prognostic accuracy of
the qSOFA and lactate criteria (defined
as two or more qSOFA criteria, and
venous lactate concentration higher
than the defined cut-off) in an emer-
gency department of a hospital with
limited resources, in comparison with










67 (5379) 30/777(3.8) To evaluate the accuracy of early warning
scores (NEWS, MEWS, MEDS and SOS)
and compare them with qSOFA and
SIRS in detecting sepsis and predicting
hospital admission and mortality in










72.6 (15.4) 457/1622(28.18) To validate and compare the clinical util-
ity of REMS, SIRS, qSOFA, and NEWS in
























(Number of death /
Total number of
patients, %)
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Score evaluated
mortality within 7 days of admission
in ED patients with suspected sepsis
Pairattanakorn et al
(2020)[44]
Thailand prospective all wards 65.74 (17.84) 117/409 (28.6) To determine the diagnostic performance
of SIRS score, qSOFA score, SOFA score,
MEWS, and NEWS for sepsis detection
and mortality prediction in adult
patients suspected of having sepsis at







Minn et al (2021)
[45]
Myanmar prospective General wards 48 (29-64) 75/434(17.28) To determine the ability of several com-
monly used disease severity scores to
predict the clinical course of patients
with evidence of community-acquired
sepsis in resource-limited tropical set-
tings like Myanmar
Not reported qSOFA UVA




72.5(13.7) 191/365(52.32) To investigate the predictive capacity of
the SOFA score, SIRS, qSOFA, and
qSOFA + lactate criteria (qSOFA+L) cri-
teria in
the diagnosis and prognosis of sepsis





47.5 (18.1) 54/180(30) To assess the prognostic accuracy of
qSOFA score in predicting adverse out-
comes in patients with suspected
infections and to compare it with the
SIRS (Systemic Inflammatory Response
Syndrome) and the SOFA (Sequential













Figure 2. Forest plots for mortality by A qSOFA; B SIRS; C MEWS and D UVA scores.
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studies was 0¢70 (95% CI 0¢600¢78); the pooled specificity was 0¢73
(95% CI 0¢670¢79) (Figure 2A); and the pooled AUC was 0¢77 (95% CI
0¢720¢82). SIRS pooled sensitivity and specificity for predictingmortal-
ity were 0¢88 (95% CI 0¢79 -0¢93) and 0¢34 (95% CI 0¢250¢44)(Figure 2B), respectively; the pooled AUC was 0¢69 (95% CI 0¢500¢83).
MEWS pooled sensitivity and specificity were 0¢70 (95% CI 0¢57 -0¢81)
and 0¢61 (95% CI 0¢420¢77) (Fig. 2C), respectively; the pooled AUC was
0¢72 (95% CI 0¢640¢77). UVA sensitivity and specificity were 0¢49 (95%
CI 0¢33 -0¢65) and 0¢91 (95% CI 0¢840¢96) (Figure 2 D), respectively;
8 B.R. Adegbite et al. / EClinicalMedicine 42 (2021) 101184the pooled AUC 0¢76 (95% CI 0¢440¢93). In the subgroup analysis
assessing the performance of qSOFA in ICU vs outside of ICU, the sensi-
tivity and the AUC of qSOFA in predictingmortality was better in studies
assessing its performance in ICU compared with non-ICU areas (sensi-
tivity 0¢96 [95% 0¢90; 0¢98] vs 0¢61 [95% CI 0¢52; 0¢68]); AUC: 0¢95 [95%
CI 0¢90- 0¢97] vs 0¢72 [95 % 0¢68- 0¢75] respectively). The specificity did
not differ considerably (0¢67 [95% CI 0¢13; 0¢87] vs 0¢74 [95% CI 0¢69;
0¢79]). Due to a limited number of studies assessing the other scores, a
subgroup analysis was not performed.
In those studies simultaneously reporting the accuracy of a posi-
tive qSOFA score and positive SIRS criteria for predicting mortality,
the qSOFA score was more specific but less sensitive than SIRS;
qSOFA, MEWS, and UVA performed similarly (Table 2).
Three studies that reported the prognostic performance of posi-
tive qSOFA scores in predicting acute organ dysfunction; the pooled
sensitivity, specificity, and AUC were 0¢43 (95% CI 0¢30 -0¢57), 0¢85
(95% CI 0¢78 -0¢90), and 0¢76 (95% CI 0¢5 -0¢86), respectively. The
pooled performance of SIRS in the diagnosis of acute organ dysfunc-
tion was as follows: sensitivity 0¢87 (95% CI 0¢58 -0¢97); specificity
0¢30 (95% CI 0¢11 -0¢59); and AUC 0¢62 (95% CI 0¢35 -0¢85).
4. Discussion
In this systematic review and meta-analysis, the prognostic capa-
bility of qSOFA, SIRS, MEWS, and UVA for predicting mortality and
organ dysfunction in adult patients with suspected infection or sepsis
in LMICs was evaluated. The performance of qSOFA outside of ICU in
our systematic review is lower to what was reported in the original
study assessing the performance of qSOFA (0¢72 (95% CI 0¢68-0¢75) vs
81(95% CI 0¢800¢82)) [22]. It is also lower than the performance
(0¢78 (95% CI, 0¢720¢84)) reported in 2018 in a systematic review
including both HICs and LMICs [23]. The sensitivity of qSOFA in this
systematic review, however, is higher than that determined by the
systematic review which included studies from HICs only (0¢76; 95%
CI 0¢590¢88 vs 0¢58; 95% CI 0¢470¢67) [24]. The difference in the
performance of qSOFA in HICs as compared to LMICs could be due to
patient characteristics and differences in the respective infectious
disease burden, as well as variation in healthcare resources, and the
degree to which definitive diagnostics are available (such as CT or
MRI scans, bronchoscopy etc.). Furthermore, the mechanisms that
lead to life-threatening acute organ dysfunction from infections such
as malaria, tuberculosis, and HIV which are more prevalent in LMICs
can differ from those of classic bacterial sepsis [25,26]. Some studies
suggest the combination of qSOFA with biomarkers, such as C-reative
protein and procalcitonin, to increase its sensitivity [27]. The Sepsis
3.0 task force designed qSOFA criteria to replace SIRS to identify
patients with suspected infection who would require early diagnosis
and treatment. However, our meta-analysis demonstrates that qSOFA
had a poor sensitivity for predicting mortality as compared with SIRS.
To that end, SIRS should not be abandoned as it could provide utility
in a staged approach with qSOFA, whereby SIRS is used as a primaryTable 2
Pooled performance characteristics comparison of qSOFA and SIRS criteria for
predicting mortality in patients with suspected infection
Scores Sensitivity (95% CI) Specificity (95% CI) AUC (95% CI)
qSOFA vs SIRS
qSOFA 0¢72 (0¢58-0¢82) 0¢67(0¢55-0¢79) 0¢74(0¢680¢78)
SIRS 0¢88(0¢79- 0¢93) 0¢34(0¢25- 0¢44) 0¢56(0¢40-0¢76)
qSOFA vs MEWS
qSOFA 0¢58(0¢35-0¢78) 0¢78(0¢62-0¢88) 0¢73(0¢63-0¢79)
MEWS 0¢74(0¢58-0¢86) 0¢55(0¢35-0¢74) 0¢69(0¢65-0¢74)
qSOFA vs UVA
qSOFA 0¢50 (0¢17; 0¢82) 0¢79(0¢51; 0¢94) 0¢69(0¢53 -0¢78)
UVA 0¢45(0¢24; 0¢68) 0¢92(0¢82; 0¢96) 0¢77(0¢47 -0¢87)screening tool to identify patients requiring a high level of care, and
qSOFA is applied subsequently for predicting mortality; an approach
which to the best of our knowledge has not yet been investigated sys-
tematically.
The comparison of MEWS and qSOFA performance (AUC) in pre-
dicting mortality showed that they performed similarly (0¢73 (95% CI
0¢63-0¢79) vs 0¢69 (95% CI 0¢65-0¢74)). However, the sensitivity of
MEWS is higher than that of qSOFA. When a high sensitivity trigger is
used, it is more likely that the patient will be identified sooner. How-
ever, if a ‘sepsis bundle’ is administered to patients who ultimately
do not have sepsis, there is a risk of over-treatment, and there are
substantial concerns about excessive fluid administration and antibi-
otic use [28] In LMIC settings, patients with HIV have an increased
risk for developing sepsis [25]. In our meta-analysis, the UVA score
had the highest specificity (0¢92, 95% CI 0¢82; 0¢96). The UVA was
reported as an appropriate score to assess in-hospital mortality risk in
adults, and derived exclusively from data from six sub-Saharan African
countries [29]; further prospective validation would be helpful.
Pathogen spectrum and clinical presentation of sepsis may be dif-
ferent between LMICs and high-income settings. Due to the lack of
human resources and ICU facilities in LMICs, there is a need to
develop reliable triage scores to determine who requires the highest
available level of care. Our meta-analysis demonstrates that there is
no single top-performing score. Future studies should investigate the
performance of amalgamated (i.e. combining the best of different
scores) and combined scores (staged using sensitivity score, followed
by the more specific) in various countries.
Our review has several limitations. First, there was considerable
heterogeneity between the studies included. Second, the definition of
suspected infection varied among studies; and due to the retrospec-
tive design of many studies, these differences would have introduced
selection bias. Third, we were unable to directly compare the four
scores because there was one study simultaneously reporting the
performance of these scores.
In conclusion, there is not a single score which ultimately identi-
fies, with accuracy, patients with suspected infections or sepsis at
high risk of death or clinical condition deterioration. Amongst the
scores readily at hand, SIRS could be applied to first screening to
identify those patients requiring high-level care, followed by qSOFA,
MEWS, or UVA scores, based both on published performance indica-
tors and subject to local availability of data collection tools, for mor-
tality prediction. There is a need to perform further studies to
validate the UVA score. In general, future studies should investigate
the performance of combined or sequential use of scores, or their
amalgamation, i.e. optimalisation by combining selected or modified
elements of different scores. This altogether could help to further
improve patient triage in resource-limited environments and serve
as a standard for mortality risk in future studies.
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